*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach - as a primary procedure code | 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach - as a primary or secondary procedure code | |
|---|---|---|
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | 56,781 | 121,248 |
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | 82,487 | 157,871 |
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total Medicare Hospitalizations after Exclusion | ||
| Avg. LOS | ||
| Readmission Rate (%) | ||
| Unplanned Readmission Rate (%) | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 15,889 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 19.26 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 6.73 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 21.31 | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 17.14 | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $227,150,345 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $2,124 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $14,296 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $814,666,673 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $51,272 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 10.86 | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 29.76 | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 25.99 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 195: SIMPLE PNEUMONIA AND PLEURISY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 443,386 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 3,253 | ||||
| DRG Share of Total Hospitalizations | 1.35 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 3.94 | ||||
| Avg LOS at DRG | 5.27 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 5.66 | ||||
| Readmission Rate at DRG | 21.6 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 19.92 | ||||
| Unplanned Readmission Rate at DRG | 15.91 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 16.53 | ||||
| Total Medicare payments at DRG | $3,812,834,208 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $35,927,937 | ||||
| Total Medicare payment per Day at DRG | $1,632 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $1,953 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,599 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $11,045 | ||||
| Total Medicare Charges at DRG | $18,110,468,211 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $129,742,187 | ||||
| Avg Charges at DRG | $40,846 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $39,884 | ||||
| Mortality Rate at DRG | 3.59 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 3.84 | ||||
| SNF Discharge Rate at DRG | 22.57 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 25.21 | ||||
| Home Discharge Rate at DRG | 40.95 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 37.29 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 602: CELLULITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 231,410 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 1,547 | ||||
| DRG Share of Total Hospitalizations | 0.7 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 1.88 | ||||
| Avg LOS at DRG | 7.29 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 7.69 | ||||
| Readmission Rate at DRG | 25.54 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 24.94 | ||||
| Unplanned Readmission Rate at DRG | 18.36 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 21.5 | ||||
| Total Medicare payments at DRG | $2,801,759,007 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $23,669,182 | ||||
| Total Medicare payment per Day at DRG | $1,661 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $1,990 | ||||
| Total Medicare payment per Hospitalization at DRG | $12,107 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $15,300 | ||||
| Total Medicare Charges at DRG | $13,366,030,360 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $81,662,727 | ||||
| Avg Charges at DRG | $57,759 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $52,788 | ||||
| Mortality Rate at DRG | 7.21 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 8.53 | ||||
| SNF Discharge Rate at DRG | 32.47 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 32.9 | ||||
| Home Discharge Rate at DRG | 20.84 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 20.69 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 434,264 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 838 | ||||
| DRG Share of Total Hospitalizations | 1.32 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 1.02 | ||||
| Avg LOS at DRG | 3.94 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 4.55 | ||||
| Readmission Rate at DRG | 22.76 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 19.32 | ||||
| Unplanned Readmission Rate at DRG | 16.46 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 16.31 | ||||
| Total Medicare payments at DRG | $2,472,138,198 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $6,112,860 | ||||
| Total Medicare payment per Day at DRG | $1,444 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $1,602 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,693 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $7,295 | ||||
| Total Medicare Charges at DRG | $12,478,361,060 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $24,549,949 | ||||
| Avg Charges at DRG | $28,735 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $29,296 | ||||
| Mortality Rate at DRG | 0.91 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | NA | ||||
| SNF Discharge Rate at DRG | 22.02 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 26.49 | ||||
| Home Discharge Rate at DRG | 46.68 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 38.31 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| NEW YORK - PRESBYTERIAN/QUEENS | 56-45 MAIN STREET | NEW YORK | NY | 11355 | 5,369 |
| MONTEFIORE MEDICAL CENTER | 111 E 210TH ST | BRONX | NY | 10467 | 4,351 |
| NEWYORK PRESBYTERIAN - WEILL CORNELL MEDICAL CENTER | 525 E 68TH ST | NEW YORK | NY | 10021 | 4,293 |
| THE UNIVERSITY OF TENNESSEE MEDICAL CENTER | 1924 ALCOA HWY | KNOXVILLE | TN | 37920 | |
| CROUSE HOSPITAL | 736 IRVING AVE | SYRACUSE | NY | 13210 | |
| SENTARA RMH MEDICAL CENTER | 2010 HEALTH CAMPUS DR | HARRISONBURG | VA | 22801 | |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | |
| ST. JOSEPH HOSPITAL | 4295 HEMPSTEAD TPKE | BETHPAGE | NY | 11714 | |
| MOUNT SINAI WEST | 1000 10TH AVE | NEW YORK | NY | 10019 | |
| SENTARA MARTHA JEFFERSON HOSPITAL | 500 MARTHA JEFFERSON DR | CHARLOTTESVILLE | VA | 22911 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. JAMES F WITKO | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 413 |
| Dr. REMBERTO J BITAR | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 372 |
| Dr. TERRANCE J TRUITT | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 360 |
| Dr. ROXANA ELENA LAZARESCU | 5645 MAIN ST | FLUSHING | NY | 11355 | |
| Dr. YURI SERGEY FINK | 4078 NOSTRAND AVE | BROOKLYN | NY | 11235 | |
| Dr. OLENA GUZHVA | 200 BOUNDARY AVE | MASSAPEQUA | NY | 11758 | |
| Dr. NEEL MANN | 333 BROADWAY | AMITYVILLE | NY | 11701 | |
| Dr. ROBERT GROSS | 6425 LYNCH CANYON DR | LAKE ISABELLA | CA | 93240 | |
| Dr. JOSEPH P. CAMERO | 1710 E SAUNDERS ST | LAREDO | TX | 78041 | |
| Dr. JONATHAN JAMES KOERTEN | 1924 ALCOA HWY | KNOXVILLE | TN | 37920 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. JAMES F WITKO | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 426 |
| Dr. TERRANCE J TRUITT | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 385 |
| Dr. REMBERTO J BITAR | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 376 |
| Dr. ROXANA ELENA LAZARESCU | 5645 MAIN ST | FLUSHING | NY | 11355 | |
| Dr. YURI SERGEY FINK | 4078 NOSTRAND AVE | BROOKLYN | NY | 11235 | |
| Dr. OLENA GUZHVA | 200 BOUNDARY AVE | MASSAPEQUA | NY | 11758 | |
| Dr. ROBERT GROSS | 6425 LYNCH CANYON DR | LAKE ISABELLA | CA | 93240 | |
| Dr. NEEL MANN | 333 BROADWAY | AMITYVILLE | NY | 11701 | |
| Dr. JOSEPH P. CAMERO | 1710 E SAUNDERS ST | LAREDO | TX | 78041 | |
| Dr. WILLIAM R TOCK | 100 HOSPITAL DR | BENNINGTON | VT | 05201 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 24,183 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 15.32 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 7.3 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 23.2 | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 18.43 | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $360,346,421 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $2,042 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $14,901 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $1,456,996,465 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $60,249 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 13.86 | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 29.9 | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 23.45 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 443,386 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 4,701 | ||||
| DRG Share of Total Hospitalizations | 1.35 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 2.98 | ||||
| Avg LOS at DRG | 5.27 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 6.07 | ||||
| Readmission Rate at DRG | 21.6 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 21.36 | ||||
| Unplanned Readmission Rate at DRG | 15.91 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 17.36 | ||||
| Total Medicare payments at DRG | $3,812,834,208 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $54,799,749 | ||||
| Total Medicare payment per Day at DRG | $1,632 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $1,921 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,599 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $11,657 | ||||
| Total Medicare Charges at DRG | $18,110,468,211 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $208,226,505 | ||||
| Avg Charges at DRG | $40,846 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $44,294 | ||||
| Mortality Rate at DRG | 3.59 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 4.49 | ||||
| SNF Discharge Rate at DRG | 22.57 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 25.16 | ||||
| Home Discharge Rate at DRG | 40.95 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 36.12 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 195: SIMPLE PNEUMONIA AND PLEURISY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 269,064 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 2,875 | ||||
| DRG Share of Total Hospitalizations | 0.82 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 1.82 | ||||
| Avg LOS at DRG | 13.18 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 16.05 | ||||
| Readmission Rate at DRG | 37.51 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 34.52 | ||||
| Unplanned Readmission Rate at DRG | 18.15 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 23.47 | ||||
| Total Medicare payments at DRG | $9,344,186,034 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $126,701,677 | ||||
| Total Medicare payment per Day at DRG | $2,635 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $2,745 | ||||
| Total Medicare payment per Hospitalization at DRG | $34,728 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $44,070 | ||||
| Total Medicare Charges at DRG | $44,371,117,432 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $485,787,200 | ||||
| Avg Charges at DRG | $164,909 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $168,969 | ||||
| Mortality Rate at DRG | 14.37 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 18.57 | ||||
| SNF Discharge Rate at DRG | 31.8 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 40.31 | ||||
| Home Discharge Rate at DRG | 14.61 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 11.79 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 870: SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 99,217 | ||||
| Total Hospitalizations with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 2,051 | ||||
| DRG Share of Total Hospitalizations | 0.3 | ||||
| % of Total ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach in DRG | 1.3 | ||||
| Avg LOS at DRG | 14.88 | ||||
| Avg LOS with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 16.78 | ||||
| Readmission Rate at DRG | 41.65 | ||||
| Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 39.6 | ||||
| Unplanned Readmission Rate at DRG | 18.54 | ||||
| Unplanned Readmission Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 30.84 | ||||
| Total Medicare payments at DRG | $4,073,197,631 | ||||
| Total Medicare payments with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $104,312,847 | ||||
| Total Medicare payment per Day at DRG | $2,758 | ||||
| Total Medicare payment per Day with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $3,031 | ||||
| Total Medicare payment per Hospitalization at DRG | $41,053 | ||||
| Total Medicare payment per Hospitalization with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $50,860 | ||||
| Total Medicare Charges at DRG | $20,258,140,795 | ||||
| Total Medicare Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $374,155,314 | ||||
| Avg Charges at DRG | $204,180 | ||||
| Avg Charges with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | $182,426 | ||||
| Mortality Rate at DRG | 35.07 | ||||
| Mortality Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 35.74 | ||||
| SNF Discharge Rate at DRG | 25.76 | ||||
| SNF Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 41.35 | ||||
| Home Discharge Rate at DRG | 4.34 | ||||
| Home Discharge Rate with ICD 3E03329 - Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | 2.1 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| NEW YORK - PRESBYTERIAN/QUEENS | 56-45 MAIN STREET | NEW YORK | NY | 11355 | 11,421 |
| NEWYORK PRESBYTERIAN - WEILL CORNELL MEDICAL CENTER | 525 E 68TH ST | NEW YORK | NY | 10021 | 11,104 |
| MONTEFIORE MEDICAL CENTER | 111 E 210TH ST | BRONX | NY | 10467 | 10,610 |
| CONEY ISLAND HOSPITAL | 2601 OCEAN PKWY | BROOKLYN | NY | 11235 | |
| THE UNIVERSITY OF TENNESSEE MEDICAL CENTER | 1924 ALCOA HWY | KNOXVILLE | TN | 37920 | |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | |
| ST. JOSEPH HOSPITAL | 4295 HEMPSTEAD TPKE | BETHPAGE | NY | 11714 | |
| CROUSE HOSPITAL | 736 IRVING AVE | SYRACUSE | NY | 13210 | |
| STATEN ISLAND UNIVERSITY HOSPITAL | 475 SEAVIEW AVE | STATEN ISLAND | NY | 10305 | |
| UNIVERSITY OF MARYLAND MEDICAL CENTER | 22 S GREENE STREET | BALTIMORE | MD | 21201 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. JAMES F WITKO | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 576 |
| Dr. GREGORY GOIKHBERG | 2601 OCEAN PKWY | BROOKLYN | NY | 11235 | 549 |
| Dr. DAVID M ROGERS | 5645 MAIN ST | FLUSHING | NY | 11355 | 541 |
| Dr. REMBERTO J BITAR | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | |
| Dr. TERRANCE J TRUITT | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | |
| Dr. YURI SERGEY FINK | 4078 NOSTRAND AVE | BROOKLYN | NY | 11235 | |
| Dr. ROXANA ELENA LAZARESCU | 5645 MAIN ST | FLUSHING | NY | 11355 | |
| Dr. OLENA GUZHVA | 200 BOUNDARY AVE | MASSAPEQUA | NY | 11758 | |
| Dr. ROBERT GROSS | 6425 LYNCH CANYON DR | LAKE ISABELLA | CA | 93240 | |
| Dr. FELIKS CHECHELNIKER | 312 NEPTUNE AVE | BROOKLYN | NY | 11235 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. GREGORY GOIKHBERG | 2601 OCEAN PKWY | BROOKLYN | NY | 11235 | 696 |
| Dr. JAMES F WITKO | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | 643 |
| Dr. ANN MARIE SWANN | 100 HOSPITAL DR | BENNINGTON | VT | 05201 | 571 |
| Dr. TERRANCE J TRUITT | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | |
| Dr. REMBERTO J BITAR | 2210 WILBORN AVE | SOUTH BOSTON | VA | 24592 | |
| Dr. WILLIAM R TOCK | 100 HOSPITAL DR | BENNINGTON | VT | 05201 | |
| Dr. YURI SERGEY FINK | 4078 NOSTRAND AVE | BROOKLYN | NY | 11235 | |
| Dr. ROXANA ELENA LAZARESCU | 5645 MAIN ST | FLUSHING | NY | 11355 | |
| Dr. OLENA GUZHVA | 200 BOUNDARY AVE | MASSAPEQUA | NY | 11758 | |
| Dr. FELIKS CHECHELNIKER | 312 NEPTUNE AVE | BROOKLYN | NY | 11235 |